医药产业智能化转型，人工智能ETF（159819）、恒生创新药ETF（159316）等助力布局产业发展机遇

Market Performance - The CSI Artificial Intelligence Theme Index and the CSI Cloud Computing and Big Data Theme Index both fell by 1.2% [1] - The National Robot Industry Index and the CSI New Energy Index decreased by 1.7% [1] - The Hang Seng Hong Kong Stock Connect Innovative Drug Index dropped by 1.9% [1] Company Collaboration - Sinopharm Group and Huawei are set to deepen their collaboration, focusing on the integration of pharmaceuticals and artificial intelligence [1] - High-level discussions have confirmed joint efforts in digital top-level planning and the development and application of pharmaceutical large models [1] - Since 2020, both companies have partnered in various fields including digital transformation and pharmaceutical distribution, leveraging AI to enhance drug development efficiency and optimize clinical diagnosis [1]